Advisory Research’s Exelixis EXEL Stock Holding History

Advisory Research’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-58,609	Closed	-$1.44M	–	443
2017 Q2	$1.44M	Buy	+58,609	New	+$1.24M	0.02%	270

Other funds holding EXEL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Advisory Research's EXEL Position: Q3 2017 in Review

Advisory Research sold out of Exelixis (EXEL) in Q3 2017, closing a stake of 58,609 shares — an estimated $1.44M sold.

Advisory Research first reported a position in EXEL in Q2 2017 and held it in 1 quarter. The position peaked at $1.44M in Q2 2017. 264 funds tracked by Wall St. Rank hold EXEL as of Q3 2017.

Advisory Research reported no remaining Exelixis position as of Q3 2017 after selling out during the quarter.
Advisory Research sold 58,609 Exelixis shares in Q3 2017, an estimated $1.44M.
Advisory Research first reported a position in Exelixis in Q2 2017 and held it in 1 quarter.
Advisory Research's Exelixis position peaked at $1.44M in Q2 2017.
264 funds tracked by Wall St. Rank held Exelixis as of Q3 2017.

Based on Advisory Research's 13F filing for Q3 2017, filed 14 Nov 2017.